Wellmarker Bio executives are celebrating the Bio Grand Prize award. / ⓒ Wellmarker Bio.
In October, 2021, the '7th Korea's Good Company Awards' were announced to appreciate entrepreneurs that are continuously showing high R&D performance, contributing to the development of influential technologies.
Among the 10 different sectors, Wellmarker Bio has been awarded Grand 'BIO' Prize for accelerating the creation of novel anticancer drugs through its in-house technology.
Please click on the link below to read the full news provided in Korean.